Nephropathy of type 1 and type 2 diabetes: diverse pathophysiology, same treatment?
Authors:
- Piero RuggenentiPRPiero Ruggenenti
- Giuseppe RemuzziGiuseppe Remuzzi
Open Access
- 1 December 2000
- journal article
- editorial
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 15 (12) , 1900-1902
Abstract
Diabetic nephropathy is a syndrome of albuminuria, declining glomerular filtration rate (GFR), arterial hypertension, and increased cardiovascular risk that affects 20–40% of type 1 (insulin‐dependent) and type 2 (non insulin dependent) diabetic patients [1–3]. Diabetics, mostly type 2, account for about one third of all patients requiring chronic renal replacement therapy in western countries. Indeed, type 2 diabetics with end‐stage renal disease (ESRD) are rapidly increasing because of the continuing increase in the prevalence of type 2 diabetes and the progressively declining mortality rate from cardiovascular causes. The costs associated with management of the disease (in 1996, $4.6 billion in the United States alone) are increasing in proportion and will soon become unbearable for most western countries. High mortality, costs, and decreased quality of life associated with chronic renal replacement therapy, have motivated the search for the causes and the possible treatments that might effectively delay or even completely prevent the progression of diabetic nephropathy to ESRD.Keywords
This publication has 18 references indexed in Scilit:
- Nephropathy in Patients with Type 2 Diabetes MellitusNew England Journal of Medicine, 1999
- Glomerular size-selective dysfunction in NIDDM is not ameliorated by ACE inhibition or by calcium channel blockadeKidney International, 1999
- Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised studyThe Lancet, 1999
- Pathophysiology of Progressive NephropathiesNew England Journal of Medicine, 1998
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- The Effect of Nisoldipine as Compared with Enalapril on Cardiovascular Outcomes in Patients with Non-Insulin-Dependent Diabetes and HypertensionNew England Journal of Medicine, 1998
- Insulin LisproNew England Journal of Medicine, 1997
- The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic NephropathyNew England Journal of Medicine, 1993
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Risk factors for development of microalbuminuria in insulin dependent diabetic patients: a cohort study. Microalbuminuria Collaborative Study Group, United Kingdom.BMJ, 1993